iSpecimen Inc.
iSpecimen Inc. (ISPC): ~3 mo cash runway. Updated within the last hour.
BioSniper Score
2-factor signal · derived from public data
2.7 months
D/E 7.12 · 0% dilution
N/A
N/A
N/A
N/A
A transparent, data-derived signal for iSpecimen Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$3.9M
Cash
$2.8M
Quarterly Burn
$3.4M
Runway
2.7 mo
Revenue
$156K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Frequently asked questions
What is iSpecimen Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, iSpecimen Inc. has approximately 2.7 months of cash runway.
What is iSpecimen Inc.'s market capitalization?
iSpecimen Inc.'s market capitalization is approximately $3.9M.
Who is the CEO of iSpecimen Inc.?
Ms. Katharyn Field is the chief executive officer of iSpecimen Inc. (ISPC).
Get the full picture on iSpecimen Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.